TIDMSN.
RNS Number : 5626E
Smith & Nephew Plc
11 March 2022
SMITH & NEPHEW PLC
11 March 2022
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE
REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND
PERSONS CLOSELY ASSOCIATED WITH THEM.
1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2010 AND 2020
On 9 March 2022, the following awards of US$0.20 ordinary shares
(the "Shares") in Smith & Nephew plc (the "Company") vested
under the Smith & Nephew Global Share Plan 2010 and 2020.
i. PARTIAL VESTING ON 9 MARCH 2022 OF 2020 EQUITY INCENTIVE
PROGRAMME AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:
The awards were granted under the Global Share Plan 2010 on 9
March 2020. One third of the Shares vested on 9 March 2021, a
further third vested on 9 March 2022 and the final third will vest
on 9 March 2023. A number of Shares were sold to cover taxation
obligations arising on the vesting of the awards. The number of
Shares acquired includes the dividend equivalent Shares which
participants receive on vested Shares.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
----------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
----------------------------------------------
LEI 213800ZTMDN8S67S1H61
----------------------------------------------
Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
Description of the Smith & Nephew plc ordinary shares of
financial instrument, USD 0.20 each
type of instrument
----------------------------------------------
Identification code ISIN: GB0009223206
----------------------------------------------
Nature of the transaction Partial vesting of Equity Incentive Programme
awards granted on 9 March 2020 under
the Smith & Nephew Global Share Plan
2010 .
----------------------------------------------
Date of Transaction 2022 - 03 - 09
----------------------------------------------
Place of Transaction London Stock Exchange (XLON)
----------------------------------------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Name Price Aggregated the transaction the transaction
(Position) Status (GBP) Volume information * *
2,372
(of which
1,119
Helen Barraclough were sold 21,613.75378
(Group General and 1,253 N/A Single ordinary
Counsel) PDMR 12.105 retained) Transaction shares 0.00244%
---------- ------- --------------- ------------- ------------------- -----------------
Bradley Cannon 5,713
(President, (of which 90,693.17832
Orthopaedics, 1,934 ordinary
Sports Medicine were sold shares (including
& ENT and and 3,779 N/A Single 2,718.50860
Americas) PDMR 12.105 retained) Transaction in ADS') 0.01025%
---------- ------- --------------- ------------- ------------------- -----------------
3,823
Phil Cowdy (of which
(Chief Business 1,803
Development were sold 49,153.96621
& Corporate and 2,020 N/A Single ordinary
Affairs Officer) PDMR 12.105 retained) Transaction shares 0.00555%
---------- ------- --------------- ------------- ------------------- -----------------
2,980
(of which
0 were
Myra Eskes sold and 5,908.68131
(President 2,980 N/A Single ordinary
APAC Region) PDMR 12.105 retained) Transaction shares 0.00067%
---------- ------- --------------- ------------- ------------------- -----------------
Simon Fraser
(President, 3,802
Advanced (of which
Wound Management 1,131
& Global were sold 18,104.59428
Commercial and 2,671 N/A Single ordinary
Operations) PDMR 12.105 retained) Transaction shares 0.00205%
---------- ------- --------------- ------------- ------------------- -----------------
5,105
(of which 116,837.00000
2,011 ordinary
Elga Lohler were sold shares (including
(Chief HR and 3,094 N/A Single 3,015.00
Officer) PDMR 12.105 retained) Transaction in ADS') 0.01320%
---------- ------- --------------- ------------- ------------------- -----------------
4,945
(of which
Vasant Padmanabhan 1,837
(President were sold 74,561.00000
Research and 3,108 N/A Single ordinary
& Development) PDMR 12.105 retained) Transaction shares 0.00842%
---------- ------- --------------- ------------- ------------------- -----------------
1,716
(of which
Susan Swabey 810 were 53,168.39347
(Company sold and N/A Single ordinary
Secretary) PDMR 12.105 906 retained) Transaction shares 0.00601%
---------- ------- --------------- ------------- ------------------- -----------------
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
ii. PARTIAL VESTING ON 9 MARCH 2022 OF 2021 EQUITY INCENTIVE
PROGRAMME AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
The awards were granted under the Global Share Plan 2020 on 9
March 2021. One third of the Shares vested on 9 March 2022, a
further third will vest on 9 March 2023 and the final third will
vest on 9 March 2024. A number of Shares were sold to cover
taxation obligations arising on the vesting of the awards. The
number of Shares acquired includes the dividend equivalent Shares
which participants receive on vested Shares.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
----------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
----------------------------------------------
LEI 213800ZTMDN8S67S1H61
----------------------------------------------
Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
Description of the Smith & Nephew plc ordinary shares of
financial instrument, USD 0.20 each
type of instrument
----------------------------------------------
Identification code ISIN: GB0009223206
----------------------------------------------
Nature of the transaction Partial vesting of Equity Incentive Programme
awards granted on 9 March 2021 under
the Smith & Nephew Global Share Plan
2020 .
----------------------------------------------
Date of Transaction 2022 - 03 - 09
----------------------------------------------
Place of Transaction London Stock Exchange (XLON)
----------------------------------------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Name Price Aggregated the transaction the transaction
(Position) Status (GBP) Volume information * *
2,932
(of which
1,383
Helen Barraclough were sold 23,162.75378
(Group General and 1,549 N/A Single ordinary
Counsel) PDMR 12.105 retained) Transaction shares 0.00262%
---------- ------- ----------- ------------- ------------------- -----------------
Bradley Cannon 6,692
(President, (of which 95,118.17832
Orthopaedics, 2,267 ordinary
Sports Medicine were sold shares (including
& ENT and and 4,425 N/A Single 2,718.50860
Americas) PDMR 12.105 retained) Transaction in ADS') 0.01074%
---------- ------- ----------- ------------- ------------------- -----------------
1,673
(of which
477 were
Peter Coenen sold and 1,196.00000
(President 1,196 N/A Single ordinary
EMEA Region) PDMR 12.105 retained) Transaction shares 0.00014%
---------- ------- ----------- ------------- ------------------- -----------------
5,366
Phil Cowdy (of which
(Chief Business 2,531
Development were sold 51,988.966.21
& Corporate and 2,835 N/A Single ordinary
Affairs Officer) PDMR 12.105 retained) Transaction shares 0.00587%
---------- ------- ----------- ------------- ------------------- -----------------
5,839
(of which
0 were
Myra Eskes sold and 11,747.68131
(President 5,839 N/A Single ordinary
APAC Region) PDMR 12.105 retained) Transaction shares 0.00133%
---------- ------- ----------- ------------- ------------------- -----------------
Simon Fraser
(President, 4,851
Advanced (of which
Wound Management 1,444
& Global were sold 21,511.59428
Commercial and 3,407 N/A Single ordinary
Operations) PDMR 12.105 retained) Transaction shares 0.00243%
---------- ------- ----------- ------------- ------------------- -----------------
5,980
(of which 120,466.00000
2,351 ordinary
Elga Lohler were sold shares (including
(Chief HR and 3,629 N/A Single 3,015.00000
Officer) PDMR 12.105 retained) Transaction in ADS') 0.01361%
---------- ------- ----------- ------------- ------------------- -----------------
4,958
(of which
Vasant Padmanabhan 1,840
(President were sold 77,679.00000
Research and 3,118 N/A Single ordinary
& Development) PDMR 12.105 retained) Transaction shares 0.00877%
---------- ------- ----------- ------------- ------------------- -----------------
2,358
(of which
1,112
Susan Swabey were sold 54,414.39347
(Company and 1,246 N/A Single ordinary
Secretary) PDMR 12.105 retained) Transaction shares 0.00615%
---------- ------- ----------- ------------- ------------------- -----------------
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
iii. PARTIAL VESTING ON 9 MARCH 2022 OF CONDITIONAL SHARE AWARDS
MADE UNDER THE GLOBAL SHARE PLAN 2010:
The awards were granted under the Global Share Plan 2010 on 9
March 2020. One third of the shares vested on 9 March 2021, a
further third vested on 9 March 2022 and the final third will vest
on 9 March 2023. A number of Shares were sold to cover taxation
obligations arising on the vesting of the awards.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
------------------------------------------
LEI 213800ZTMDN8S67S1H61
------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
Description of the Smith & Nephew plc ordinary shares of USD
financial instrument, 0.20 each
type of instrument
------------------------------------------
Identification code ISIN: GB0009223206
------------------------------------------
Nature of the transaction Partial vesting of a Conditional Share
Award granted on 9 March 2020 under the
Smith & Nephew Global Share Plan 2010.
------------------------------------------
Date of Transaction 2022 - 03 - 09
------------------------------------------
Place of Transaction London Stock Exchange (XLON)
------------------------------------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Name Price Aggregated the transaction the transaction
(Position) Status (GBP) Volume information * *
Bradley Cannon 6,546
(President, (of which 99,446.17832
Orthopaedics, 2,218 ordinary
Sports Medicine were sold shares (including
& ENT and and 4,328 N/A Single 2,718.50860
Americas) PDMR 12.105 retained) Transaction in ADS') 0.01123%
---------- ------- ----------- ------------- ------------------- -----------------
4,603
Phil Cowdy (of which
(Chief Business 2,172
Development were sold 54,419.96621
& Corporate and 2,431 N/A Single ordinary
Affairs Officer) PDMR 12.105 retained) Transaction shares 0.00615%
---------- ------- ----------- ------------- ------------------- -----------------
6,594
(of which
0 were
Myra Eskes sold and 18,341.68131
(President 6,594 N/A Single ordinary
APAC Region) PDMR 12.105 retained) Transaction shares 0.00207%
---------- ------- ----------- ------------- ------------------- -----------------
Simon Fraser
(President, 5,608
Advanced (of which
Wound Management 1,669
& Global were sold 25,450.59428
Commercial and 3,939 N/A Single ordinary
Operations) PDMR 12.105 retained) Transaction shares 0.00288%
---------- ------- ----------- ------------- ------------------- -----------------
5,849
(of which 124,010.00000
2,305 ordinary
Elga Lohler were sold shares (including
(Chief HR and 3,544 N/A Single 3,015.00000
Officer) PDMR 12.105 retained) Transaction in ADS') 0.01401%
---------- ------- ----------- ------------- ------------------- -----------------
5,610
(of which
Vasant Padmanabhan 2,083
(President were sold 81,206.00000
Research and 3,527 N/A Single ordinary
& Development) PDMR 12.105 retained) Transaction shares 0.00917%
---------- ------- ----------- ------------- ------------------- -----------------
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
2. AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020
On 9 March 2022 the following awards of US$0.20 ordinary shares
(the "Shares") in Smith & Nephew plc (the "Company") were
granted under the Smith & Nephew Global Share Plan 2020. The
awards have been made in London and are based on the closing Share
price on the London Stock Exchange on 8 March 2022 of
GBP11.975.
i. DEFERRED BONUS PLAN AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020:
A portion of the annual bonus earned by the following PDMRs for
performance during the year to 31 December 2021 has been deferred
into a share award. These awards will normally vest in equal annual
tranches over three years following the award date, subject to
continued achievement of objectives and employment. In the event
that objectives are not met in any of the three years, the portion
of shares due to vest on the following anniversary will lapse.
Participants will receive an additional number of shares equivalent
to the amount of dividend payable per vested share during the
relevant performance period.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
--------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
--------------------------------------------
LEI 213800ZTMDN8S67S1H61
--------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
Description of the Smith & Nephew plc Ordinary Shares of USD
financial instrument, 0.20 each
type of instrument
--------------------------------------------
Identification code ISIN: GB0009223206
--------------------------------------------
Nature of the transaction Deferred Bonus Plan awards granted on 9
March 2022 under the Smith & Nephew Global
Share Plan 2020.
--------------------------------------------
Date of Transaction 2022 - 03 - 09
--------------------------------------------
Place of Transaction Grant took place outside a trading venue
--------------------------------------------
Name Status Price (s) Volume(s) Aggregated information
(Position)
Helen Barraclough PDMR GBP11.975 5,021 N/A Single Transaction
(Group General
Counsel)
------- ---------- ---------- -----------------------
Bradley Cannon PDMR GBP11.975 18,215 N/A Single Transaction
(President, Orthopaedics,
Sports Medicine
& ENT and Americas)
------- ---------- ---------- -----------------------
Peter Coenen PDMR GBP11.975 7,195 N/A Single Transaction
(President EMEA
Region)
------- ---------- ---------- -----------------------
Phil Cowdy PDMR GBP11.975 8,231 N/A Single Transaction
(Chief Business
Development & Corporate
Affairs Officer)
------- ---------- ---------- -----------------------
Myra Eskes PDMR GBP11.975 11,868 N/A Single Transaction
(President APAC
Region)
------- ---------- ---------- -----------------------
Simon Fraser PDMR GBP11.975 17,668 N/A Single Transaction
(President, Advanced
Wound Management
& Global Commercial
Operations)
------- ---------- ---------- -----------------------
Mizanu Kebede PDMR GBP11.975 2,084 N/A Single Transaction
(Chief Quality
and Regulatory
Affairs Officer)
------- ---------- ---------- -----------------------
Elga Lohler PDMR GBP11.975 11,747 N/A Single Transaction
(Chief HR Officer)
------- ---------- ---------- -----------------------
Vasant Padmanabhan PDMR GBP11.975 9,503 N/A Single Transaction
(President Research
& Development)
------- ---------- ---------- -----------------------
Susan Swabey PDMR GBP11.975 3,582 N/A Single Transaction
(Company Secretary)
------- ---------- ---------- -----------------------
3. AWARDS MADE UNDER THE DEFERRED SHARE BONUS PLAN 2020
On 9 March 2022 the following awards of US$0.20 ordinary shares
(the "Shares") in Smith & Nephew plc (the "Company") were
granted under the Smith & Nephew Deferred Share Bonus Plan
2020. The awards have been made in London and are based on the
closing Share price on the London Stock Exchange on 8 March 2022 of
GBP11.975.
ii. DEFERRED BONUS PLAN AWARDS GRANTED UNDER THE SMITH &
NEPHEW DEFERRED SHARE BONUS PLAN 2020:
A portion of the annual bonus earned by the following Executive
Directors for performance during the year to 31 December 2021 has
been deferred into a share award. These awards will vest on 9 March
2025 for the Executive Directors, subject to continued achievement
of objectives and employment. The participants will be required to
hold the shares after tax, for a further period of two years to 9
March 2027. Participants will receive an additional number of
shares equivalent to the amount of dividend payable per vested
share during the relevant performance period.
The following relates to individuals included in the below
notification:
Reason for the notification
Initial notification Initial notification
/Amendment
----------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
----------------------------------------------
LEI 213800ZTMDN8S67S1H61
----------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
Description of the Smith & Nephew plc Ordinary Shares of USD
financial instrument, 0.20 each
type of instrument
----------------------------------------------
Identification code ISIN: GB0009223206
----------------------------------------------
Nature of the transaction Deferred Bonus Plan awards granted on 9
March 2022 under the Smith & Nephew Deferred
Share Bonus Plan 2020.
----------------------------------------------
Date of Transaction 2022 - 03 - 09
----------------------------------------------
Place of Transaction Grant took place outside a trading venue
----------------------------------------------
Name Status Price (s) Volume(s) Aggregated information
(Position)
Roland Diggelmann Director GBP11.975 42,113 N/A Single Transaction
(Chief Executive
Officer)
--------- ---------- ---------- -----------------------
Anne-Françoise Director GBP11.975 24,169 N/A Single Transaction
Nesmes
( Chief Financial
Officer)
--------- ---------- ---------- -----------------------
4. PHIL COWDY - SALE OF ORDINARY SHARES
Reason for the notification
Initial notification Initial notification
/Amendment
------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
------------------------------------------
LEI 213800ZTMDN8S67S1H61
------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
Description of the Smith & Nephew plc ordinary shares of USD
financial instrument, 0.20 each
type of instrument
------------------------------------------
Identification code ISIN: GB0009223206
------------------------------------------
Nature of the transaction Sale of ordinary shares.
------------------------------------------
Date of Transaction 2022 - 03 - 10
------------------------------------------
Place of Transaction London Stock Exchange (XLON)
------------------------------------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Director Aggregated the transaction the transaction
Name (Position) / PDMR Price (GBP) Volume information * *
Phil Cowdy
(Chief Business
Development 47,133.96621
& Corporate N/A Single ordinary
Affairs Officer) PDMR 12.145 7,286 Transaction shares 0.00532%
---------- ------------ ------- ------------- ----------------- -----------------
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFERVEILLIF
(END) Dow Jones Newswires
March 11, 2022 12:00 ET (17:00 GMT)
Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Smith & Nephew (LSE:SN.)
Storico
Da Apr 2023 a Apr 2024
